Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic Entity
Emory University · Surrey Memorial Hospital · +18 more institutions
Abstract
Oncogenic osteomalacia (OO) is a rare paraneoplastic syndrome of osteomalacia due to phosphate wasting. The phosphaturic mesenchymal tumor (mixed connective tissue variant) (PMTMCT) is an extremely rare, distinctive tumor that is frequently associated with OO. Despite its association with OO, many PMTMCTs go unrecognized because they are erroneously diagnosed as other mesenchymal tumors. Expression of fibroblast growth factor-23 (FGF-23), a recently described protein putatively implicated in renal tubular phosphate loss, has been shown in a small number of mesenchymal tumors with known OO. The clinicopathological features of 32 mesenchymal tumors either with known OO (29) or with features suggestive of PMTMCT…
Citation impact
- FWCI
- 6.75
- Percentile
- 100%
- References
- 110
Authors
25- ALAndrew L. FolpeCorresponding
Emory University, Surrey Memorial Hospital, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis
- JCJulie C. Fanburg–Smith
Massachusetts General Hospital, Mayo Clinic in Arizona, Armed Forces Institute of Pathology
- SDSteven D. Billings
University of Washington Medical Center, Dermatopathologie Friedrichshafen, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis
- MBMichele Bisceglia
Johns Hopkins University, Johns Hopkins Medicine, Casa Sollievo della Sofferenza, Armed Forces Institute of Pathology, Istituti di Ricovero e Cura a Carattere Scientifico
- FBFranco Bertoni
Charles University, London Health Sciences Centre, University of Bologna
Topics & keywords
- Pathology
- Hemangiopericytoma
- Mesenchymal stem cell
- CD34
- Osteoid
- Medicine
- Vimentin
- Osteosarcoma